ANGIOTENSIN RECEPTOR GENES AND BLOOD PRESSURE REGULATION

血管紧张素受体基因和血压调节

• 批准号: 6051360
• 负责人: THOMAS M COFFMAN
• 金额: $ 24.93万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-01-01 至 2003-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6051360
• 关键词: angiotensin II; angiotensin receptor; blood pressure; electrolyte balance; gene targeting; genetic regulation; genetically modified animals; ion transport; kidney function; laboratory mouse; receptor expression; receptor sensitivity; renal tubular transport; renin angiotensin system; sodium ion; vascular smooth muscle

In the previous funding period, we developed and characterized mouse models with targeted mutations of the two murine AT1 receptor genes, Agtr1a and Agtr1b. These studies demonstrated: (a) the importance of AT1 receptor genes in blood pressure and sodium homeostasis (b) a hierarchy for physiological importance of the two AT1 receptor genes (Agtr1a>>>Agtr1b) (c) the essential actions of AT1 receptors to maintain vascular and papillary structures in the kidney and the key role of AT1 receptor signaling in the kidney to regulate blood pressure. In this application, we will continue our studies of the physiological roles of AT1 receptor genes focusing on their actions in the kidney. AT1 receptors are expressed in distinct cellular compartments in the kidney and we posit that these expression patterns reflect distinct actions of AT1 receptors to regulate kidney structure and function. We will test this hypothesis and define the contribution of these cellular compartments to maintenance of blood pressure using transgenic mouse models through the following specific aims: (1) Using a cross-transplantation approach that was developed in the previous funding period, to characterize physiological responses of mice that lack or express AT1 receptors only in the kidney. (2) To determine contribution of AT1 receptors expressed in epithelial compartments in the kidney to maintaining blood pressure sodium homeostasis. (3) To determine whether expression of AT1 receptors in vascular smooth muscle cells is sufficient to restore normal levels of blood pressure in mice that otherwise lack AT1A receptors. (4) To define the role of tissue specific expression of AT1 receptors in preventing the severe renal structural abnormalities caused by AT1 receptor-deficiency. These studies will define the physiological importance of AT1 receptor signaling in the kidney and will compare the relative contribution of epithelial and vascular actions of AT1 receptors in regulating blood pressure.

在之前的资助期间，我们开发并表征了具有两种小鼠 AT1 受体基因 Agtr1a 和 Agtr1b 靶向突变的小鼠模型。这些研究证明：(a) AT1 受体基因在血压和钠稳态中的重要性 (b) 两个 AT1 受体基因 (Agtr1a>>>Agtr1b) 的生理重要性的层次结构 (c) AT1 受体维持肾脏血管和乳头结构的基本作用以及 AT1 受体信号在肾脏中调节血压的关键作用。在此应用中，我们将继续研究 AT1 受体基因的生理作用，重点关注它们在肾脏中的作用。 AT1 受体在肾脏的不同细胞区室中表达，我们认为这些表达模式反映了 AT1 受体调节肾脏结构和功能的独特作用。我们将测试这一假设，并通过以下具体目标，使用转基因小鼠模型来定义这些细胞区室对维持血压的贡献：（1）使用上一资助期间开发的交叉移植方法，来表征仅在肾脏中缺乏或表达 AT1 受体的小鼠的生理反应。 (2)确定肾脏上皮区室中表达的AT1受体对维持血压钠稳态的贡献。 (3) 确定血管平滑肌细胞中 AT1 受体的表达是否足以恢复缺乏 AT1A 受体的小鼠的正常血压水平。 (4)明确AT1受体的组织特异性表达在预防AT1受体缺陷引起的严重肾脏结构异常中的作用。这些研究将定义 AT1 受体信号在肾脏中的生理重要性，并将比较 AT1 受体在调节血压中上皮和血管作用的相对贡献。